Search
Search Results
##search.searchResults.foundPlural##
-
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1485PDF: 878HTML: 1934Figure: 150Tables: 166ALL revision 1: 174response to reviewer: 159 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1329PDF: 656HTML: 1068Untitled: 165Untitled: 130Untitled: 114Untitled: 137Untitled: 143 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2182PDF: 854HTML: 1980Fig 1 Rossi: 154 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1974PDF: 1461HTML: 259 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2131PDF: 923HTML: 5023Cover Letter: 152Figure 2: 140Figure 1: 150Figure 3: 168Figure 4: 150Figure Legend: 165Table 1: 165Table 2: 160Table 3: 159 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1242PDF: 775HTML: 114 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3770PDF: 1410HTML: 8487 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3301PDF: 1248HTML: 2192Fi.1 Gritti.Rambaldi: 185 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1176PDF: 555HTML: 2840ATRA induced Reactive Hemophagocytosis: A Case Report: 178 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3829PDF: 1442HTML: 9171Untitled: 259Untitled: 163Untitled: 149Untitled: 145Untitled: 163Untitled: 316 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2867PDF: 980HTML: 4562 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1935PDF: 737HTML: 3101 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2520PDF: 1569HTML: 2337Table1: 176 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
903PDF: 460HTML: 65 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1035PDF: 469HTML: 8135 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3308PDF: 1263HTML: 1849Fig.1: 182Fig. 2: 188 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3637PDF: 1605HTML: 11494Figures Haase: 177 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1306PDF: 835HTML: 7908Untitled: 186 -
Osteolytic bone lesions – A rare presentation of AML M6.
1925PDF: 1052HTML: 7899Untitled: 186 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2250PDF: 1542HTML: 580 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3958PDF: 1012HTML: 3556Untitled: 164Cneo. Fig.1: 99Untitled: 89Untitled: 112Untitled: 114 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7693PDF: 3983HTML: 7294 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
925PDF: 664HTML: 211 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1119PDF: 1006HTML: 175 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1223PDF: 739HTML: 4345Figure 1: 143Untitled: 109Untitled: 158 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1411PDF: 513HTML: 661 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1643PDF: 1066HTML: 6500original file with images: 250







